Investors Snag NKTR 9.0% Cheaper Than Its Secondary Stock Offering
January 18, 2017 at 09:59 AM EST
Looking back to 92 days ago, Nektar Therapeutics (NKTR) priced a 13,000,000 share secondary stock offering at $13.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..